Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,983 | 203 | 98.3% |
| Education | $32.73 | 2 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,278 | 91 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $417.54 | 32 | $0 (2023) |
| Gilead Sciences, Inc. | $408.23 | 21 | $0 (2021) |
| Janssen Biotech, Inc. | $257.71 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $98.81 | 7 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $94.73 | 4 | $0 (2018) |
| Allergan Inc. | $71.71 | 5 | $0 (2018) |
| PFIZER INC. | $59.67 | 4 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $49.03 | 3 | $0 (2021) |
| Celgene Corporation | $43.28 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $395.87 | 29 | ABBVIE INC. ($223.05) |
| 2023 | $437.95 | 29 | AbbVie Inc. ($316.80) |
| 2022 | $486.26 | 41 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($203.80) |
| 2021 | $433.43 | 32 | AbbVie Inc. ($180.82) |
| 2020 | $83.23 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($43.56) |
| 2019 | $458.63 | 28 | AbbVie, Inc. ($253.92) |
| 2018 | $339.14 | 24 | AbbVie, Inc. ($86.64) |
| 2017 | $401.45 | 17 | Gilead Sciences Inc ($185.54) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/06/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: VIROLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: General - Hemostasis_ENDO | ||||||
| 08/14/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Immunology | ||||||
| 07/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: VIROLOGY | ||||||
| 04/10/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $15.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Immunology | ||||||
| 03/12/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Immunology | ||||||
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 833 | 905 | $822,435 | $103,297 |
| 2022 | 13 | 758 | 793 | $709,210 | $89,819 |
| 2021 | 14 | 773 | 831 | $742,535 | $95,647 |
| 2020 | 11 | 667 | 709 | $635,925 | $67,811 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 205 | $30,750 | $21,604 | 70.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 106 | 106 | $174,900 | $14,820 | 8.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 134 | 140 | $210,000 | $13,592 | 6.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 65 | 65 | $143,000 | $12,236 | 8.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 76 | 76 | $136,800 | $9,973 | 7.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $18,900 | $8,325 | 44.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 24 | 24 | $39,600 | $4,730 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 55 | $6,875 | $4,150 | 60.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $13,250 | $3,983 | 30.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $24,750 | $2,951 | 11.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 16 | $4,800 | $2,372 | 49.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 30 | $7,500 | $2,029 | 27.1% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 18 | 22 | $8,800 | $1,395 | 15.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 24 | 24 | $2,400 | $1,090 | 45.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 11 | 11 | $110.00 | $47.19 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 156 | $23,400 | $15,757 | 67.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 101 | 101 | $166,650 | $14,176 | 8.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 89 | 89 | $160,200 | $12,442 | 7.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 55 | 55 | $121,000 | $11,289 | 9.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 96 | 99 | $148,500 | $9,324 | 6.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $20,100 | $8,899 | 44.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 65 | 65 | $16,250 | $5,542 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 65 | $8,125 | $4,793 | 59.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 21 | 21 | $34,650 | $4,220 | 12.2% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2022 | 14 | 17 | $6,800 | $1,415 | 20.8% |
About Dr. Michael Schmidt, MD
Dr. Michael Schmidt, MD is a Specialist healthcare provider based in Teaneck, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710951348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Schmidt, MD has received a total of $3,036 in payments from pharmaceutical and medical device companies, with $395.87 received in 2024. These payments were reported across 206 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,983).
As a Medicare-enrolled provider, Schmidt has provided services to 3,031 Medicare beneficiaries, totaling 3,238 services with total Medicare billing of $356,574. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Teaneck, NJ
- Active Since 02/13/2006
- Last Updated 07/26/2017
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1710951348
Products in Payments
- RINVOQ (Biological) $279.52
- LINZESS (Drug) $212.58
- XIFAXAN (Drug) $195.67
- TRULANCE (Drug) $175.63
- SKYRIZI (Biological) $172.10
- Creon (Drug) $171.81
- STELARA (Biological) $161.35
- Mavyret (Drug) $135.86
- Epclusa (Drug) $108.59
- HUMIRA (Biological) $107.32
- Trulance (Drug) $94.73
- MAVYRET (Drug) $77.11
- REMICADE (Biological) $76.09
- Humira (Biological) $57.00
- VIBERZI (Drug) $53.74
- Linzess (Drug) $49.03
- MOVIPREP (Drug) $47.82
- ENTYVIO (Biological) $45.62
- ZEPOSIA (Drug) $43.28
- XELJANZ (Drug) $42.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Teaneck
Dr. Peter Hersh, M.d, M.D
Specialist — Payments: $72,201
Adam Palance, Md, MD
Specialist — Payments: $11,766
Dr. Ebrahim Issa
Specialist — Payments: $7,680
Dr. Christopher Brown, M.d, M.D
Specialist — Payments: $5,561
Philip Micale, M.d, M.D
Specialist — Payments: $4,402
Dr. Payal Shah
Specialist — Payments: $3,938